DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis

Clinical Epigenetics

Volumn 7, Issue 1, 2015, Pages

  Lleo, Ana ^a   Zhang, Weici ^e   Zhao, Ming ^b   Tan, Yixin ^b   Bernuzzi, Francesca ^a   Zhu, Bochen ^b   Liu, Qian ^b   Tan, Qiqun ^b   Malinverno, Federica ^c   Valenti, Luca ^c   Jiang, Tingting ^b   Tan, Lina ^b   Liao, Wei ^b   Coppel, Ross ^d   Invernizzi, Pietro ^a,e   Lu, Qianjin ^b   Adams, David H ^f   Gershwin, M Eric ^e  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

CXCR3; Primary biliary cirrhosis; X chromosome

Indexed keywords

CHEMOKINE RECEPTOR CXCR3;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CD14+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; CXCR3 GENE; DEMETHYLATION; DNA METHYLATION; EPIGENETICS; FEMALE; FUNDC2 GENE; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; X CHROMOSOME;

EID: 84935064584     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/s13148-015-0098-9     Document Type: Article

References (44)

1. Sawalha AH. Epigenetics and T-cell immunity. Autoimmunity. 2008;41(4):245–52. doi:10.1080/08916930802024145.
2. Coit P, Jeffries M, Altorok N, Dozmorov MG, Koelsch KA, Wren JD, et al. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. J Autoimmun. 2013;43:78–84. doi:10.1016/j.jaut.2013.04.003.
3. Richardson BC, Patel DR. Epigenetics in 2013: DNA methylation and miRNA—key roles in systemic autoimmunity. Nat Rev Rheumatol. 2014. doi:10.1038/nrrheum.2013.211.
4. Hewagama A, Gorelik G, Patel D, Liyanarachchi P, McCune WJ, Somers E, et al. Overexpression of X-linked genes in T cells from women with lupus. J Autoimmun. 2013;41:60–71. doi:10.1016/j.jaut.2012.12.006.
5. Shimoda S, Harada K, Niiro H, Shirabe K, Taketomi A, Maehara Y, et al. Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis. Hepatology. 2011;53(4):1270–81. doi:10.1002/hep.24194.
6. Lleo A, Bowlus CL, Yang GX, Invernizzi P, Podda M, Van de Water J, et al. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology. 2010;52(3):987–98. doi:10.1002/hep.23783.
7. Invernizzi P. Primary biliary cirrhosis. Semin Liver Dis. 2014;34(3):253–4. doi:10.1055/s-0034-1383724.
8. Kita H, Matsumura S, He XS, Ansari AA, Lian ZX, Van de Water J, et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest. 2002;109(9):1231–40. doi:10.1172/JCI14698.
9. Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, He XS, et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology. 2002;123(4):1031–43.
10. Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel RL, et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest. 1998;102(10):1831–40. doi:10.1172/JCI4213.
11. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353(12):1261–73. doi:10.1056/NEJMra043898.
12. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology. 2008;47(2):737–45. doi:10.1002/hep.22042.
13. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Gu X, et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med. 2009;360(24):2544–55. doi:10.1056/NEJMoa0810440.
14. Liu X, Invernizzi P, Lu Y, Kosoy R, Bianchi I, Podda M, et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet. 2010;42(8):658–60. doi:10.1038/ng.627.
15. Mells GF, Floyd JA, Morley KI, Cordell HJ, Franklin CS, Shin SY, et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genet. 2011. doi:10.1038/ng.789.
16. Juran BD, Hirschfield GM, Invernizzi P, Atkinson EJ, Li Y, Xie G, et al. Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet. 2012;21(23):5209–21. doi:10.1093/hmg/dds359.
17. Carbone M, Lleo A, Sandford RN, Invernizzi P. Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis. Eur J Immunol. 2014;44(4):945–54. doi:10.1002/eji.201344270.
18. Lleo A, Liao J, Invernizzi P, Zhao M, Bernuzzi F, Ma L, et al. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology. 2012;55(1):153–60. doi:10.1002/hep.24630.
19. Mitchell MM, Lleo A, Zammataro L, Mayo MJ, Invernizzi P, Bach N, et al. Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics: official J of the DNA Methylation Society. 2011;6(1):95–102. doi:10.4161/epi.6.1.13405.
20. Bianchi I, Carbone M, Lleo A, Invernizzi P. Genetics and epigenetics of primary biliary cirrhosis. Semin Liver Dis. 2014;34(3):255–64. doi:10.1055/s-0034-1383725.
21. Podda M, Selmi C, Lleo A, Moroni L, Invernizzi P. The limitations and hidden gems of the epidemiology of primary biliary cirrhosis. J Autoimmun. 2013;46:81–7. doi:10.1016/j.jaut.2013.06.015.
22. Bianchi I, Lleo A, Gershwin ME, Invernizzi P. The X chromosome and immune associated genes. J Autoimmun. 2012;38(2-3):J187–92. doi:10.1016/j.jaut.2011.11.012.
23. Invernizzi P, Pasini S, Selmi C, Gershwin ME, Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun. 2009;33(1):12–6. doi:10.1016/j.jaut.2009.03.005.
24. Invernizzi P, Miozzo M, Battezzati PM, Bianchi I, Grati FR, Simoni G, et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet. 2004;363(9408):533–5. doi:10.1016/S0140-6736(04)15541-4.
25. Miozzo M, Selmi C, Gentilin B, Grati FR, Sirchia S, Oertelt S, et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology. 2007;46(2):456–62. doi:10.1002/hep.21696.
26. Lleo A, Oertelt-Prigione S, Bianchi I, Caliari L, Finelli P, Miozzo M, et al. Y chromosome loss in male patients with primary biliary cirrhosis. J Autoimmun. 2013;41:87–91. doi:10.1016/j.jaut.2012.12.008.
27. Chuang YH, Lian ZX, Cheng CM, Lan RY, Yang GX, Moritoki Y, et al. Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives. J Autoimmun. 2005;25(2):126–32. doi:10.1016/j.jaut.2005.08.009.
28. Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernizzi P, Gish RG, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology. 2004;127(2):485–92.
29. Richardson BC. Epigenetics and autoimmunity. Overview. Autoimmunity. 2008;41(4):243–4. doi:10.1080/08916930802024129.
30. Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, Rodriguez-Ubreva J, et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res. 2010;20(2):170–9. doi:10.1101/gr.100289.109.
31. Stefan M, Zhang W, Concepcion E, Yi Z, Tomer Y. DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology. J Autoimmun. 2013. doi:10.1016/j.jaut.2013.10.001.
32. Shimoda S, Ishikawa F, Kamihira T, Komori A, Niiro H, Baba E, et al. Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory. Gastroenterology. 2006;131(2):606–18. doi:10.1053/j.gastro.2006.05.056.
33. Lohr H, Fleischer B, Gerken G, Yeaman SJ, Meyer zum Buschenfelde KH, Manns M. Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopes and the pyruvate dehydrogenase complex. J Hepatol. 1993;18(3):322–7.
34. Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol. 2010;52(5):745–58. doi:10.1016/j.jhep.2009.11.027.
35. Ramesh R, Kozhaya L, McKevitt K, Djuretic IM, Carlson TJ, Quintero MA, et al. Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med. 2014;211(1):89–104. doi:10.1084/jem.20130301.
36. Duhen T, Campbell DJ. IL-1beta promotes the differentiation of polyfunctional human CCR6+CXCR3+ Th1/17 cells that are specific for pathogenic and commensal microbes. J Immunol. 2014;193(1):120–9. doi:10.4049/jimmunol.1302734.
37. O’Connor RA, Li X, Blumerman S, Anderton SM, Noelle RJ, Dalton DK. Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system. J Immunol. 2012;188(5):2093–101. doi:10.4049/jimmunol.1101118.
38. Oo YH, Weston CJ, Lalor PF, Curbishley SM, Withers DR, Reynolds GM, et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol. 2010;184(6):2886–98. doi:10.4049/jimmunol.0901216.
39. Antonelli A, Ferrari SM, Giuggioli D, Ferrannini E, Ferri C, Fallahi P. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmun Rev. 2014;13(3):272–80. doi:10.1016/j.autrev.2013.10.010.
40. Zhang W, Fei Y, Gao J, Liu B, Zhang F. The role of CXCR3 in the induction of primary biliary cirrhosis. Clin Dev Immunol. 2011;2011:564062. doi:10.1155/2011/564062.
41. Groom JR, Richmond J, Murooka TT, Sorensen EW, Sung JH, Bankert K, et al. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. Immunity. 2012;37(6):1091–103. doi:10.1016/j.immuni.2012.08.016.
42. Chomczynski P, Mackey K. Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques. 1995;19(6):942–5.
43. Fraga MF, Esteller M. DNA methylation: a profile of methods and applications. Biotechniques. 2002;33(3):632. 4, 6-49.
44. Lugli E, Gattinoni L, Roberto A, Mavilio D, Price DA, Restifo NP, et al. Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells. Nat Protoc. 2013;8(1):33–42. doi:10.1038/nprot.2012.143.